申请人:Dainippon Sumitomo Pharma Co., Ltd.
公开号:US08063223B2
公开(公告)日:2011-11-22
Disclosed is a benzylpiperizine compound represented by formula (1) or a pharmaceutically acceptable salt thereof, which is useful as a medicinal agent such as an antidepressant agent. (In the formula (1), R1 represents a hydrogen atom or a methyl group; R2 is a group bound in a p- or m-position relative to a methylene group and represents a chlorine atom bound in a p-position, a bromine atom bound in a p-position, a methyl group bound in a p-position, a chlorine atom bound in a m-position or a bromine atom bound to in a m-position; X represents a methylene or an oxygen atom; and n represents an integer of 1 to 3.)
本发明公开了一种苯基哌嗪化合物,其化学式为(1),或其药学上可接受的盐,该化合物可用作药物,例如抗抑郁药物。在化学式(1)中,R1表示氢原子或甲基基团;R2是与亚甲基基团相对的p-或m-位置上的结合基团,表示在p-位置上结合的氯原子、在p-位置上结合的溴原子、在p-位置上结合的甲基基团、在m-位置上结合的氯原子或在m-位置上结合的溴原子;X表示亚甲基或氧原子;n表示1到3的整数。